fi$a de verificarb...medic/ medic dentist/farmacist primar in specialitatea postului (la...
Post on 15-Nov-2020
16 Views
Preview:
TRANSCRIPT
FI$A DE VERIFICARB
a indeplinirii standardelor minimale in vederea obfinerii atestatului de abilitare
in cadrul I.O.S.U.D. Universitatea de Medicinl gi Farmacie "Carol Davila" Bucureqti
Domeniile de doctorat: Medicini, Farmacie
I. Date despre candidat
Nume:STANICA
Prenume:TUDOR HORIA
1. Doctor in qtiinfe
X n,q. tr NU
Titlul tezei de doctorat: "Membranele neovasculare subretiniene - posibilitS{i
terapeutice" - Coordonator Stiintific Prof. Dr. Benone CArstocea
Ordinul de confirmare: Ordinul Ministrului Educatiei, Cercetlrii qi Inovirii nr.
4542 din28.07.2010/ Diploml seria G nr. 0001497
2. Medic/ medic dentist/farmacist primar in specialitatea postului (la disciplinele cu
corespondent in refeaua Ministerului Siniti{ii)
Xoa trNU
Ordinul de confirmare: Ordinul M.S. nr.l276 din 30.09.2010; Certicat seria PlNr.002386
II. Date numerice privind indeplinirea standardelor minimale na{ionale, conform anexelor
nr. 20 qi 23 ale Ordinului Ministrului Educafiei Na{ionale pi Cercetlrii $tiin{ifice nr.
6129t20.12.2016
Standard minimCriteriul
Numir articole Publicate in
reviste cotate ISI in calitate
de autor PrinciPal
l. Articole publicate in reviste cotate ISI in calitate de autor principal
Criteriu indePlinit:
X n,l trNU
Lista articolelor ISI publicate in calitate de autor principal: autori, titlu articol, revistl, an,
volum, pagini, factor de imPact
APl Stanca H.T., Petrovi6 2., Munteanu
reasonable method to reperfuse occluded
Nov;71(l l):1072-7.
ISI Impact Factor 0.292.
AP2 Stanca H.T., Suvac E., Munteanu M., Jianu D'C',
..Giant cell arteritis with arteritic anterior ischemic optic
2017;58(1):281-285.
ISI Impact Factor 0,912.
M. "Transluminal Nd:YAG laser embolysis - a
branch retinal arteries". Vojnosanit Ptegl. 2014
Motoc A.G.M., Rogca G.C., Boruga, O.
neuropathy". Rom J MorPhol Embryol.
Ap3 Andoni M, Savoiu Balint G, Vlaia V, Popovici AR, Stanca HT. "The Effect of Mecury
Contamination on Human Health and a Comparative Method of Extracting Hg(II) from Water
solution". Rev. Chim (Buchaiest)2017;68 (5): 925-927; ISSN 0034'7752.
ISI Impact Factor 1,412-
AP4 Savoiu Balint G, Iovanescu G, Stanca HT (corresponding author), Popoiu CM, Boia E,
Popovici AR, Bolintineanu SL. "The Protective Effect of HDl-Cholesterol in Patients with
Essential Hypertension". Rev. Chim (Bucharest) 2017;68 (5):949-952; ISSN a$4-7752.
ISI Impact Factor 1,412.
AP5 Andoni M, Savoiu Balint G, Simu GM, Popovici AR, Stanca HT. "Study Regarding the
Presence of Zn(II) in Thermal Waters for Cosmetic IJse". Rev.Chim.(Bucharest) 2017; 68 (7):
1565-t567 ; ISSN 0034-77 52.
ISI Impact Factor 1,412.
AP6 Munteanu, M., Rosca, C., Stanca, H.T."Sub-inner limiting membrane hemorrhage in a
patient with Terson syndrome". Int Ophthalmol. 2019 Feb; 39(2):461-464. doi: 10.10071s10792-
018-0822-5. Epub 2018 Jan 17.
ISI Impact Factor 1,132.
AP7 Stanca H.T., Munteanu M., Jianu D.C., Motoc A.G.M., Jecan C.R., T6bacaru B., Stanca
S., Preda M.A." Femtosecond-LASlK outcomes using the VisuMax@-MEL@ 80 platform for
mixed astigmatism refractive surgery". Rom J Morphol Embryol.2018;59(l):277-283.
ISI Impact Factor 1,5.
AP8 Balica NC, Poenaru M, Dorog CI, Baderca F, preda MA, Iovan VC, Stanca rrT(corresponding author), Busuioc CJ, Oprigcan IC, Boruga O. "The management of the
oropharyngeal anterior wall cancer". Rom J Morphol Embryol. 2018;59(1):113-119.
ISI Impact Factor lr5.
AP9 Boruga O., Stanca H.T. (corresponding author), Bagiu I.C., Horhat I.D., Craciunescu M.,
Cosnita A., Berceanu Vaduva, D., ChercotaY., Milcu A.I., Iovan C. "Incidence of Resistance
Phenotypes of Escherichia coli Strains Isolated from an Obstetrics and Gynecology UnitUnicentric Prospective Transversal Study". Rev. Chim (Bucharest) 2018; 69 (4):1023-1025.
ISI Impact Factor 1,605.
Ap10 stanca II.T., Munteanu M., Jianu D.C., Motoc A.G.M., TSbdcaru B', stanca s''
Ungureanu E., Boruga V.M., Preda M.A." New perspectives in the use of laser diode transscleral
cyclophotocoagulation. A prospective single center observational cohort study". Rom J Morphol
Embryol. 20 1 8;59(3):869 -87 2 -
ISI Impact Factor 1r5.
AP|l Stanca II. T., Stanca S., Tabacaru B., Boruga M', Balta F'"Bevacizumab in Wet AMD
treatment: A tribute to the thirteen years of experience from the beginning of the anti-VEGF era
in Romania,,. Experimental and Therapeutic Medicine 18, no. 6 (20L9): 4993-5000'
https ://doi. org/ 1 0. 3 89 2l etm.2019. 7 8 5 8'
ISI Impact Factor 1,448
AP12 Stanca, S., Ulmeanu, C. E., Stanca, II. T. (corresponding author), Iovanescu'
G.,,Clinical features in toxic coma in children". Experimental and Therapeutic Medicine 18, no' 6
(2019):5082-5087.https://doi'org/10'3892letm'2019'7857'
ISI Impact Factor 1,448.
Ap13 Popovici RA, vaduv aD,PinzaruI, Dehelean cA, Farcas cG, coricovac D, Danciu c,
popescu I, Alexa E,LazarearuV, Stanca HT. "A comparative study on the biological activity
of essential oil and total hydro-alcoholic extract of Satureja hortensis L"' Exp Ther Med' 2019
Aug;18(2): g32-g42. doi: 10.38921etm.2019.7635. Epub 2019 May 31.
ISI Impact Factor 1,448.
AP14 Freda, M.A., Karancsi, o.L., MUnteanu, M., Stanca, H.T. ,,Clinical outcomes of
micropulse transscleral cyclophotocoagUlation in refractory glaucoma-lS months follow-up"'
Lasers in Medical Science (2020) https://doi.org/10.1007/s10103-019-02934-x'
ISI Impact Factor 2,076.
AP15 Danielescu, C., Stanca, Il.T.(corresponding author), Balta, F. ,, The Management of
Lamellar Macular Holes: A Review". Hindawi Journal of Ophthalmology Volume 2020, Article
ID 3 5263 I 6, 1 0 pages, https ://doi. org/ 1 0. 1 I 5 5 I 2020 I 3 5263 I 6.
ISI Impact Factor 1,580.
2. Articole publicate in reviste cotate ISI in calitate de coautor
Criteriu indeplinit:
X u.l, tr NU
Lista articolelor ISI pubticate in calitate de coautor: autori, titlu articol, revisti, an, volum,
pagini, factor de impact
CAI Munteanu M, Munteanu G, Zolog I, Giuri S, Coviltir V, Stanca H, Cretu O. "Okuliire
dekompressions - retinopathie nach kombienert tiefer sklerectomie und trabekulotomie (Ocular
decompression retinopathy after combined deep sclerectomy and trabeculotomy)". Klin Monbl
Augenheilk d. 20 12 Aug;229 (8) : 83 0- 1 . doi : 1 0. 1 05 5/s-003 1 -12993 53 . Bpub 2012 Mar 1 5.
ISI Impact Factor 0.699.
CA2 Munteanu M, Petrovi6 Z, Stanca H, Rosca C, Jianu A, Boruga O. "Accidental Macular
Hole following Neodymium: YAG Posterior Capsulotomy". Srp Arh Celok Lek. 2014 Jul-
Aug;r42(7-8):468-7r.
ISI Impact Factor 0.228.
Criteriul Standard minim Realizat
Numir articole publicate in
reviste cotate ISI in calitate
de coautor
t2
CA3 Rosca C, Munteanu M, Fankhauser F, Stanca H, Balta F, Ungureanu E, Balica N, Mazilu
O, Boruga O. "Giant retinal tear complicated with subretinal lens fragment following
femtosecond laser cataract surgery". Spektrum Augenheilkd.; 28, 215-219 (2014)'
https ://doi. orgl 1 0. 1 00 7 I s007 | 7'0 | 4-023 0 -9 .
ISI Impact Factor 0,177.
CA4 Branisteanu DC, Munteanu M, Branisteanu DE, Stanca HT, Moraru A, Balta F. "Off-label
drug use - ethical challenges case study - Avastin". Revista Rom0n[ de Bioeticd, Vol. 13, Nr.3,
july - september 20L5,ISSN: 1583-5170'
ISI Impact Factor 0,462.
CAS Bratu LM, Rogobete AF, Papurica M, Sandesc D, Cradigati CA, Sarandan M, Dumache R,
popovici SE, Crisan DC, Stanca H, Tanasescu S, Bedreag OH. "Literature Research Regarding
miRNAs' Expression in the Assessment and Evaluation of the Critically I1l Polytrauma Patient
with Traumatic Brain and Spinal cord Injury". clin Lab.2016 oct l;62(10):20t9'2024. doi:
| 0 .7 7 5 4 I Clin.Lab.20 I 6. | 60327 .
ISI ImpactEactor 1,2.
CA6 papurica M, Rogobete AF, Sandesc D, Cradigati CA, Sarandan M, Crisan DC, Horhat FG,
Boruga O, Dumache R, Nilima KR, Nitu R, Stanca H, Bedreag OH. "The Expression of Nuclear
Transcription Factor Kappa B (NF-KB) in the Case of Critically Ill Polytrauma Patients with
Sepsis and Its Interactions with microRNAs". Biochem Genet. 2016 Aug;54(4):337-347. doi:
10. 1 007is 1 0 528-016-9727 -2. Eptfi 2016 i|l{.at 22-
ISI Impact Factor 0,952.
CA7 Boruga O., Balasoiu A.T., Giuri S., Munteanu M., Stanca H.T., Iovanescu G., Preda A.M.
..Caruncular late-onset junctional nevus: apropos of an anatomo-clinical observation". Rom J of
Morphol Embryol. 2018;59(1): 1 13-1 19-
ISI Impact Factor 1,5.
CA8 Jianu DC, Jianu SN, Micliu$ GD, Munteanu G, Dan TF, Bdrsan C, Munteanu M, Stanca
HT, Motoc AGM, Crefu OM. "Multiple congenital anomalies of carotid and vertebral arteries in
a patient with an ischemic stroke in the vertebrobasilar territory. Case report and review of the
literature". Rom J Morphol Embryol. 2018;59@):1279-1285.
ISI lmpact Factor 1,5.
CA9 De Moraes CG, Mansouri K, Liebmann JM, Ritch R; Triggerfish Consortium (Stanca
HT included). "Association Between 24-Hour Intraocular Pressure Monitored With Contact
Lens Sensor and Visual Field Progression in Older Adults With Glaucoma". JAMA Ophthalmol.
20 1 8 Jul I ;13 6(7):7 7 9 -7 85 . doi: I 0. 1 00 1 /jamaophthalmol. 2018.17 46.
Addendum// The Triggerfish Consortium as coauthors: Tomas Grippo,MD (Argentina); Katrin
Lorentz, MD (Germany); Antonio Duch, MD, Maria Jesus Muniesa Royo,MD, Nicola
Alejandre,MD, Aitor Lanzagorta, MD, and Fernando Hussa Herrera, MD (Spain); Jean-Philippe
Nordmann, MD, Denis Gruber,MD, Philippe Buffidre,MD, Muriel Poli, MD, Isabelle Riss, MD,
Corinne Dot,MD, and Yves Lachkar,MD (France); Suneeta Dubey, MD, and Shilpa N. Patil, MD
(India); Luca Agnifili, MD, Daniela Paoli, MD, Marco Nardi, MD, Francesco Nasini, MD,
Stefano Gandolfi, MD, Enzo D'Ambrozio,MD, and Luca Rossetti, MD (Italy); Jemaima Che
Hamzah, MD, Geetha Ramakrishnan, MD, Fang Seng Kheong, MD, and Wei Loon, MD
(Malaysia); Felix Gil Carasco,MD (Mexico); Jan Askvik, MD, and Albrecht Gerstenberger,MD
(Norway); Dorin Chiselita, MD, and Horia Stanca, MD (Romania); and Rohit Sharma, MD,
Andrew J Tatham, MD, and Fernando Hussa Herrera, MD (United Kingdom).
ISI Impact Factor 6,167.
CAl0 $tefinescu-Dima A$, Minescu MR, B[16qoiu AT, Bdl[qoiu M, Mocanu CL, Stanca HT,
Mercu! Nicolcescu MF. "Behavior pattern of early-stage ocular surface squamous cell carcinoma
in non-HfV patients". Rom J Morphol Embryol. 2019;60(2):455-461. .
ISI Impact Factor 1,5.
CAll Ochinciuc R, Ochinciuc lJ, Stanca HT, Barac R, Darabus D, Suta M, Balta F, Burcea M'
..photoreceptor assessment in focal laser-treated central serous chorioretinopathy using adaptive
optics and fundus autofluorescence". Medicine 2020:'99:15(e19536).
http ://dx.doi.orgl 1 0 :1 097/MD. 00000000000 1 9 53 6'
ISI Impact Factor 2,133
CLlz Adelman R, Parnes A, Michalewska Z, Patoliri B, Boscher C, Ducoumau D; EVRS
Macular Edema Study Group (Stanca HT included). Corrigendum to "Strategy for the
Management of Diabetic Macular Edema:.The European Vitreo-Retinal Society Macular Edema
Study". Biomed Res Int. 20t5;2015.6g4902. doi: 10.1155120151694902. Epub 2015 Dec 20. v
PMID:26798639.
EVRS Macular Edema Study Group coauthors: Walid Abdelghafar, Pierre Albinet, Saad
Alkhalifa, Jean-Paul Amar, Oscar Aragon Harrison, Luis Arrevola, Francisco J. Ascaso, Samer
Bashir, Frank Becquet, Jean-Paul Berrod, Miguel Bilhoto, Silvia Bopp, Claude Boscher'
Alexandra Brix, Perfecto E. O. R. Cagampang III, Slawomir Cisiecki, Jay F. Culotta, Marcel
Dominguez, Giuseppe Donvito, Didier Ducournau, Ahmed El Khashab, Mohamed Nagy
Elmohamady Saad, Maha Elshafei, Mario Facino, Natalia Ferreira, Ivan Fiser, Martin Flores-
Aguilar, Eric Fourmaux, Evzen Fric, Wilko Friedrichs, Rino Frisina, Piotr Fryczkowski, Stratos
Gotzaridis, H'ulya G"ungel, Fr'ed'eric Hamon, Fabian H"ohn, Doan Hong Dung, Martin
Hovorka, Angela Huiskamp, Mariano Iros, Slawomir Janiec, Young-Joon Jo, Muhammad
Shabbir Khan, Robert King, Dobromila Klimczak, Christine Kusserow,Guy L'Helgoual'ch,
Pierre-Olivier Lafontaine, Jean- Franc,ois Le Rouic, Jonghyun Lee, Oxana Levkina, Jean- Loup
Leynaud, Aliki Liaska, Selina Lin, Luis Miguel Lopez Montero, Klaus Lucke, Angelina
Meireles, Maurizio Mete, Zofia Michalewska, Janusz Michalewskr, Jeruy Nawrocki, Agnieszka
Nowosielska, Dominik Odrobina, Khor Sirwan Omer, "OzenAyranci Osmanbasoglu, Ihab Saad
Othman, Sengul Ozdek, Radu Pacurariu, Stefanie Pape, Barbara Parolini, Iwona Partyka, Enrico
Peiretti, Isabel Pinxten, Prasan Rao, Armando Razzari, Daniel Roth, Armando Sandoval,
Andreas Sch"uler, Stephen Sinclair, Peter Stalmans, Horia Stanca, Maria Stefaniotou, Yutthana
Sukonthasap,Ivan Tanev, Susana Teixeira, Dimitrios Tsouris, andZanfaZeynalova'
ISI Impact Factor 2,134.
3. Factorul cumulat de impact pentru articolele publicate ca autor principal in reviste
cotate ISI (FCIAP)
Criteriu indeplinit:
Xna trNU
Criteriul Standard minim Realizat
(ISI) Factor cumulat de
impact autor principal
10 20,677
Nr.crt. Articol ISI - autor principal Impact
Factor
I.F.
Factor de
impact
cumulat
autor
principal
FCIAP
1. Stanca H.T., Petrovi6
Nd:YAG laser embolysis
occluded branch retinal
Nov;71(11):1072-7.
2' Munteanu M. "Transluminal
- a reasonable method to reperfuse
arteries". Vojnosanit Pregl. 2014 0,29220,677
2. Stanca H.T., Suvac E., Munteanu M., Jianu D.C., Motoc
A.G.M., Roqca G.C., Boruga, O. "Giant cell arteritis with
arteritic anterior ischemic optic neuropathy". Rom J Morphol
Embryol. 20 17 ;58(l):28 I -285
0,912
3. Andoni M, Savoiu Balint G, Vlaia V, Popovici AR, Stanca
HT. "The Effect of Mecury Contamination on Human Health
and a Comparative Method of Extracting Hg(II) from Water
Solution". Rev. Chim (Bucharest); 2017; 68 (5): 925-927;
rssN 0034-77s2.
1,412
4. Savoiu Balint G, Iovanescu G, Stanca HT (corresponding
author), Popoiu CM, Boia E, Popovici AR, Bolintineanu SL'
..The Protective Effect of HDl-Cholesterol in Patients with
Essential Hypertension". Rev. Chim (Bucharest); 2017; 68
(s):949 -9 52; IS SN 0034-7 7 s2
1,412
Andoni M, Savoiu Balint G, Simu GM, Popovici AR, Stanca
HT. "Study Regarding the Presence of Zu(II) in Thermal
Waters for Cosmetic Use". REV.CHIM.(Bucharest);2017; 68
(7): 1565-1567; ISSN 0034-77s2.
1,412
6. Munteanu, M., Rosca, C., Stanca, H.T."Sub-inner limiting
membrane hemorrhage in a patient with Terson syndrome". Int
Ophthalmol. 2019 Feb; 39(2):461-464- doi: 10. 1007 lsl0792-
018-0822-5. Epub 2018 JanlT
1,132
7. Stanca H.T., Munteanu M., Jianu D.C., Motoc A.G-M., Jecan
C.R., Tdb[caru B., Stanca S., Preda M.A." Femtosecond-
LASIK outcomes using the VisuMax@-MEL@ 80 platform for
mixed astigmatism refractive surgery". Rom J Morphol
Embryol. 20 1 8;59( 1 ) :277 -283.
l15
8. Balica NC, Poenaru M, Dorog CI, Baderca F, Preda MA, Iovan
VC, Stanca IIT (corresponding author), Busuioc CJ,
Opriqcan IC, Boruga O. "The management of the
oropharyngeal anterior wall cancer". Rom J Morphol Embryol.
2018;59(1):l 13-1 19.
115
9. Boruga O., Stanca H.T. (corresponding author), Bagiu I.C.,
Horhat I.D., Craciunescu M., Cosnita A., Berceanu Vaduvd,D.,
Chercota V., Milcu A.I., Iovan C. ,.Incidence of Resistance
Phenotypes of Escherichia coli Strains Isolated from an
Obstetrics and Gynecology Unit Unicentric prospective
Transversal Study". Rev. Chim (Bucharest) 2018; 69 (4):1023-
1025.
1,605
10. Stanca [f.T., Munteanu M., Jianu D.C., Motoc A.G.M.,
Tdbicaru B., Stanca S., Ungureanu 8., Boruga V.M., preda
M.A." New perspectives in the use of laser diode transscleral
cyclophotocoagulation. A prospective single center
observational cohort study". Rom J Morphol Embryol.
2018;s9(3):869-872
115
11. Stanca H. T., Stanca S., Tabacaru B., Borugd M., Balta
F."Bevacizumab in Wet AMD treatment: A tribute to the
thirteen years of experience from the beginning of the
anti-VEGF era in Romania". Experimental and Therapeutic
Medicine 18, no. 6 (20t9): 4993-5000.
https ://doi.org/ I 0.3 89 2l etm.2019.785 8
1,448
12. Stanca, S., Ulmeanu, C. 8., Stanca, H. T. lcorresponOingauthor), Iovanescu, G."Clinical features in toxic coma in
children". Experimental and Therapeutic Medicine 18, no. 6(20 l9): 5 082-508 7. https ://doi. org/ 1 0. 3 8 92 I etm.20 tg .7 I 57 .
1,449
13. Popovici RA, VaduvaD,Pinzans I, Dehelean CA, Farcas CG,
Coricovac D, Danciu C, Popescu I, Alexa E, Laztteanl y,
stanca rrr. "A comparative study on the biological activity ofessential oil and total hydro-alcoholic extract of Satureja
hortensis L". Exp Ther Med. 2019 Atg;IS(2):932-942. doi:
10.3892/etm.2019.7635. Epub 2019 May 31,.
1,449
2,076
eanu' M'' Stanca' H'T'
,,Clinical outcornes of micropulse transscleral
cyclophotocoagulation in refractory glaucoma-l8 months
follow-up".- Lasers in Medical Science (2020)
https : //doi. org/ 1 0. 1 00 7/s 1 0 1 03 -0 19 -0293 4-x'
esPonding author)' Balta'
F. ,, The Management of Lamellar Macular Holes: A Review"'
Hindawi Joumal of Ophthalmology Volume 2020' Article ID
3 5263 | 6, 1 0 pages, https :/idoi'org/ 1 0' 1 | 5 5 I 2020 I 3 5263 I 6'
4. Indexul Hirsch
Criteriu indePlinit:
Xun trNU
l.papurica M, Rogobete AF, Sandesc D, Cradigati cA, Sarandan M, Crisan DC' Horhat FG'
Boruga o, Dumache R, Nilima KR, Nitu R, stanca H, Bedreag oH' "The Expression of Nuclear
Transcription Factor Kappa B (NF-KB) in the case of criticaily Ill porytrauma Patients with
Sepsis a-nd Its Interactions with microRNAs". Biochem Genet.2016 Aug;54(4):337-347' doi:
1 0. 1 007/s 1 0528-0 I 6-9 7 27 -z' Epub 20 1 6 Mar 22'
IF 0,952
Citations 22
Standard minim
2.De Moraes CG, Mansouri K, Liebmann JM, Ritch R; Triggerlish Consortium (Stanca HTincluded). "Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens
Sensor and Visual Field Progression in Older Adults With Glaucoma". JAMA Ophthalmol.20LgJul 1 ; 136(7):7 7 9-785. doi: 1 0. 1 00 1 /j amaophthalmo 1.20 tB.t7 46.
The Triggerfish Consortium coauthors: Tomas Grippo,MD (Argentina); Katrin Lorentz, MD(Germany); Antonio Duch, MD, Maria Jesus Muniesa Royo,MD, Nicola Alejandre,MD, AitorLanzagorta, MD, and Fernando Hussa Herrera, MD (Spain); Jean-Philippe Nordmann, MD,Denis Gruber,MD, Philippe Buffidre,MD, Muriel Poli, MD, Isabelle Riss, MD, Corinne
Dot,MD, and Yves Lachkar,MD (France); Suneeta Dubey, MD, and Shilpa N. patil, MD (India);
Luca Agnifili, MD, Daniela Paoli, MD, Marco Nardi, MD, Francesco Nasini, MD, Stefano
Gandolfi, MD, Enzo D'Ambrozio,MD, and Luca Rossetti, MD (Italy); Jemaima Che Hamzah,MD, Geetha Ramakrishnan, MD, Fang Seng'Kheong, MD, and Wei Loon, MD (Malaysia); FelixGil Carasco,MD (Mexico); Jan Askvik, MD, and Albrecht Gerstenberger,MD (Norway); DorinChiselita, MD, and Horia Stanca, MD (Romania); and Rohit Sharma, MD, Andrew J Tatham,
MD, and Fernando Hussa Herrera, MD (United Kingdom).
lF 6,167
Citations 13
3.Bratu LM, Rogobete AF, Papurica M, Sandesc D, Cradigati CA, Sarandan M, Dumache R,
Popovici SE, Crisan DC, Stanca Ir, Tanasescu S, Bedreag OH. "Literature Research Regarding
miRNAs' Expression in the Assessment and Evaluation of the Critically Ill Polytrauma patient
with Traumatic Brain and Spinal Cord Injury". Clin Lab. 2016 Oct l;62(10):2019-2024.. doi:I 0 .7 7 5 4 I Clin.Lab.20 I 6. I 60327 .
IF 1,2
Citations 7
4.BalicaNC,PoenaruM,DoroqCI'BadercaF'PredaMA'IovanVC'StancaHT(correspondingauthor),BusuiocCJ,opriqcanlC,Borugao...Themanagementofthe
oropharyngeal anterior wall cancer,,. Rom J Morphol Embryol. 2018;59(1):113-119.
rF 1,5
Citations 6
5.Savoiu Balint G, Iovanescu G, stanca HT (corresponding author), Popoiu cM' Boia E'
popovici AR, Borintineanu SL. ..The protective Effect of HDl-cholesteror in patients with
Essential Hypertension,,. Rev. Chim (Bucharest) 2017 68 (5):949.952; ISSN 0034-7752.
lB 1,412
Citations 6
6. Stanca H.T., Suvac E., Munteanu M., Jianu D.C., Motoc A.G.M., Roqca G.C., BoruEa, o.
..Giant cell arteritis with arteritic anterior ischemic optic neuropathy,,' Rom J Morphol Embryo'.
2017;s8(1):281-285 '
rF 0,912
Citations 6
Confirm prin prezenta cd datele menlionate
activitate profesionald Ei qtiinlifi cd
mai sus sunt reale qi se referd la propria mea
Semnltura
qi publica
=i?il %AT-Note usuPra metodei de calcul;
l.orevistdcotatdlslesteorevistdpentrucareThomsonReuters
factorul de impact in ,,Journal Citation Reports";
2. Autorul sau autorii principali ai unei publicalii se consid'erd a fi oricare dintre
urmdtorii:a. Primul autor
i.
4.
5.
b. Autorul corespondent
c. A$i autori, a cdror contribulie este indicatd explicit fn cadrul publica{iei a fiegald cu contribulia primului autor sau a autorului corespondent
d. Ultimul butorin analizd vor fi incluse articole originale ;i reviews. in cazul publicaliilor tn reviste
cu factor de impact mai mare decdt 3, pot fi luate tn considerare ;i alte tipuri de
publicalii in extenso (nu rezumate).
Articolele din cadrul standardelor minimale Ei obligatorii trebuie sdfie publicate, nu in curs
de publicare (nu se acceptd adeverinle).
Factorul cumulat de impact va fi calculat pentru articolele la care candidatul este
autor principal (FCIAP). FCIAP : sumafactorilor de impact ai articolelor publicate
de autor in calitate de autor principal in reviste cotate ISI;
Va fi luat in considerare Indexul Hirsch calculat utilizdnd ISI Web of Science, Core
Collection, Thomson Reuters, pentru tntreaga carierd a candidatului (,,all years");
top related